UCB - Attività Correnti





Attività Correnti Cambiamento Data
Alcon AG USD 6.62B 171M 2026-03
Almirall EUR 713.98M 69K 2025-12
Amarin USD 626.02M 23.87M 2026-03
argenx SE USD 6.9B 1.07B 2025-12
AstraZeneca USD 29.61B 890M 2026-03
Bayer EUR 35.3B 2.39B 2026-03
Genmab DKK 2.88B 1.59B 2025-12
GlaxoSmithKline GBP 17.76B 251M 2026-03
GRIFOLS EUR 5.25B 180M 2026-03
Hikma Pharmaceutical USD 2.64B 86M 2025-12
Lakefront Biotherapeutics EUR 3.06B 18.72M 2026-03
Lonza CHF 8B 3.41B 2025-12
Merck EUR 14.16B 932M 2026-03
Novartis USD 26.61B 3.85B 2026-03
Orion EUR 1.41B 66.8M 2026-03
Recordati EUR 1.73B 50.28M 2026-03
Roche Holding CHF 38.73B 3.03B 2025-12
Sanofi EUR 30.16B 789M 2026-03
UCB EUR 6.05B 733M 2025-12
Unibail Rodamco EUR 3.97B 1.09B 2025-12